CClinicalTrials.gg
Not yet recruitingNCT06067646ROMIUpdated Oct 5, 2023

Optimizing Counceling on Feeding Options of Babies From Mothers Living With HIV

An interventional study of Semistructured interview in Hiv, sponsored by Radboud University Medical Center. Not yet recruiting. Per ClinicalTrials.gov, last updated 2023-10-05.

Sponsored by Radboud University Medical Center · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as not yet recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
24
Allocation
Non-randomized
Sex
All
01

Study summary

Semi structured interviews will be performed to determine attitudes and experiences of people living with HIV and health care providers on counseling on feeding options of babies from mothers living with HIV in order to optimize counseling in the future

02

Conditions studied

  • Hiv
03

In context

Lead sponsor

Radboud University Medical Center is the lead sponsor of 959 studies on the registry; 134 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Health care provider involved in care for people living with HIV in Duth HIV treatment facility or
  • Person living with HIV + age 18-45 + prior pregnancy/desire to have children

Exclusion criteria

Exclusion Criteria:

  • Insufficient command of Dutch or English language (oral)
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
24 participants (estimated)

Study arms

  • Other
    Health care providers involved in care for people living with hiv

    Semi-structured interviews with health care providers

    Behavioral: Semistructured interview

  • Other
    People living with HIV with prior pregnancy or desire to have children

    Semi-structured interviews with people living with HIV with prior pregnancy or desire to have children

    Behavioral: Semistructured interview

Interventions

  • BehavioralSemistructured interview

    Semistructured interview and validated quality of life assesment using EQ5-DL

06

What researchers measure

Primary outcomes

  1. Experiences and attitudes on subject

    Experiences and attitudes on subject

    Time frame: Explore during semistructured interview during 1 to 2 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06067646
Lead sponsor
Radboud University Medical Center
Responsible party
Sponsor
First posted
Oct 5, 2023
Start date
Jan 2024 (estimated)
Primary completion
Dec 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Oct 5, 2023

Study contacts

Wendy van der Wekken-Pas, MD
Contact
wendy.vanderwekken-pas@radboudumc.nl
+31681485606
Angela Colbers
Contact
angela.colbers@radboudumc.nl
Angela Colbers
principal investigator · Radboud University Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion